Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by 24minus7on May 12, 2020 3:44pm
483 Views
Post# 31018804

SAIF partners / Huaxi Pharma / Wanbamg

SAIF partners / Huaxi Pharma / WanbamgAfter some research I could find out some facts: SAIF partners has a stake in Huaxi Pharma, and it seems that Mr. Victor Chao Tfchem has also visited last year or I think I recognize him https://www.sbaif.com/portfolio/beijing-huaxi-lianhe-tech-development-limited I therefore consider an investment by SAIF in SBM to be more than plausible and would consider their investment approach https://www.sbaif.com/about-saif.html SAIF also has a very strong presence in India and is represented with one main pillar, which makes the whole thing doubly interesting Some more details I could find out about Huaxi Pharm. If I add up all the investments, I come to around RMB 3 billion. (about USD 420 million). Mrs. Bi Hua (CEO) also has a stake of RMB 997 million (USD 140 million) in the company. https://m.pedaily.cn/data/company/14119 from well informed sources I know that SBM will probably launch the new website next Tuesday. Also the website of Huaxi is currently offline. Does it fit well together or just coincidence? And another link, which shows the competitive situation in the diabetes market in China https://www.biovalleyclub.com/cn/home/juhe/id/107.html
Bullboard Posts